Denali Therapeutics, Inc. (DNLI)
19.72
+0.03
(+0.15%)
USD |
NASDAQ |
Dec 09, 14:13
Denali Therapeutics Shareholders Equity (Quarterly): 926.20M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Masimo Corp. | 810.00M |
| Novavax, Inc. | -156.67M |
| iRhythm Technologies, Inc. | 121.89M |
| AIM ImmunoTech, Inc. | -6.077M |
| Protalix Biotherapeutics, Inc. | 52.91M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.056B |
| Total Liabilities (Quarterly) | 129.42M |
| Debt to Equity Ratio | 0.0479 |
| Current Ratio | 9.791 |
| Net Debt Paydown Yield | 0.04% |